BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu HG, Ai YW, Yu LL, Zhou XD, Liu J, Li JH, Xu XM, Liu S, Chen J, Liu F. Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death. Int J Cancer. 2008;122:433-443. [PMID: 17935137 DOI: 10.1002/ijc.23049] [Cited by in Crossref: 137] [Cited by in F6Publishing: 133] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Ye B, Jiang LL, Xu HT, Zhou DW, Li ZS. Expression of PI3K/AKT pathway in gastric cancer and its blockade suppresses tumor growth and metastasis. Int J Immunopathol Pharmacol 2012;25:627-36. [PMID: 23058013 DOI: 10.1177/039463201202500309] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 5.7] [Reference Citation Analysis]
2 Li M, Shan W, Hua Y, Chao F, Cui Y, Lv L, Dou X, Bian X, Zou J, Li H, Lin W. Exosomal miR-92b-3p Promotes Chemoresistance of Small Cell Lung Cancer Through the PTEN/AKT Pathway. Front Cell Dev Biol 2021;9:661602. [PMID: 34136482 DOI: 10.3389/fcell.2021.661602] [Reference Citation Analysis]
3 Chun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F, Xiao Y, Guang-Xiu W, Zhi-Fan J, Pei-Yu P, Qing-Yu Z, Chun-Sheng K. MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer 2010;10:367. [PMID: 20618998 DOI: 10.1186/1471-2407-10-367] [Cited by in Crossref: 262] [Cited by in F6Publishing: 246] [Article Influence: 21.8] [Reference Citation Analysis]
4 Chang GM, Gao YB, Wang SM, Xu XP, Zhao L, Zhang J, Li JF, Wang YL, Peng RY. Protecting intestinal epithelial cell number 6 against fission neutron irradiation through NF-κB signaling pathway. Biomed Res Int 2015;2015:124721. [PMID: 25866755 DOI: 10.1155/2015/124721] [Reference Citation Analysis]
5 Li B, Wang L, Chi B. Upregulation of periostin prevents P53-mediated apoptosis in SGC-7901 gastric cancer cells. Mol Biol Rep. 2013;40:1677-1683. [PMID: 23076534 DOI: 10.1007/s11033-012-2218-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
6 Zhang H, Zhang LQ, Yang CC, Li J, Tian XY, Li DN, Cui J, Cai JP. The high expression of NUDT5 indicates poor prognosis of breast cancer by modulating AKT / Cyclin D signaling. PLoS One 2021;16:e0245876. [PMID: 33571243 DOI: 10.1371/journal.pone.0245876] [Reference Citation Analysis]
7 Quintana M, Alegre-requena JV, Marqués-lópez E, Herrera RP, Triola G. Squaramides with cytotoxic activity against human gastric carcinoma cells HGC-27: synthesis and mechanism of action. Med Chem Commun 2016;7:550-61. [DOI: 10.1039/c5md00515a] [Cited by in Crossref: 7] [Article Influence: 1.2] [Reference Citation Analysis]
8 Xu Y, Hu Y, Xu T, Yan K, Zhang T, Li Q, Chang F, Guo X, Peng J, Li M, Zhao M, Zhen H, Xu L, Zheng D, Li L, Shao G. RNF8-mediated regulation of Akt promotes lung cancer cell survival and resistance to DNA damage. Cell Rep 2021;37:109854. [PMID: 34686341 DOI: 10.1016/j.celrep.2021.109854] [Reference Citation Analysis]
9 Reutlinger M, Koch CP, Reker D, Todoroff N, Schneider P, Rodrigues T, Schneider G. Chemically Advanced Template Search (CATS) for Scaffold-Hopping and Prospective Target Prediction for 'Orphan' Molecules. Mol Inform 2013;32:133-8. [PMID: 23956801 DOI: 10.1002/minf.201200141] [Cited by in Crossref: 101] [Cited by in F6Publishing: 89] [Article Influence: 11.2] [Reference Citation Analysis]
10 Torre C, Wang SJ, Xia W, Bourguignon LY. Reduction of hyaluronan-CD44-mediated growth, migration, and cisplatin resistance in head and neck cancer due to inhibition of Rho kinase and PI-3 kinase signaling. Arch Otolaryngol Head Neck Surg 2010;136:493-501. [PMID: 20479382 DOI: 10.1001/archoto.2010.25] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 3.8] [Reference Citation Analysis]
11 Yang WL, Wang J, Chan CH, Lee SW, Campos AD, Lamothe B, Hur L, Grabiner BC, Lin X, Darnay BG, Lin HK. The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science 2009;325:1134-8. [PMID: 19713527 DOI: 10.1126/science.1175065] [Cited by in Crossref: 378] [Cited by in F6Publishing: 373] [Article Influence: 29.1] [Reference Citation Analysis]
12 Jeong JY, Kim KS, Moon JS, Song JA, Choi SH, Kim KI, Kim TH, An HJ. Targeted inhibition of phosphatidyl inositol-3-kinase p110β, but not p110α, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancers. Apoptosis. 2013;18:509-520. [PMID: 23371322 DOI: 10.1007/s10495-013-0807-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
13 Lu C, Liu D, Jin J, Deokar H, Zhang Y, Buolamwini JK, Yu X, Yan C, Chen X. Inhibition of gastric tumor growth by a novel Hsp90 inhibitor. Biochem Pharmacol 2013;85:1246-56. [PMID: 23415900 DOI: 10.1016/j.bcp.2013.02.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
14 Lüpertz R, Chovolou Y, Unfried K, Kampkötter A, Wätjen W, Kahl R. The forkhead transcription factor FOXO4 sensitizes cancer cells to doxorubicin-mediated cytotoxicity. Carcinogenesis 2008;29:2045-52. [PMID: 18687668 DOI: 10.1093/carcin/bgn184] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
15 Riquelme I, Saavedra K, Espinoza JA, Weber H, García P, Nervi B, Garrido M, Corvalán AH, Roa JC, Bizama C. Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy. Oncotarget 2015;6:24750-79. [PMID: 26267324 DOI: 10.18632/oncotarget.4990] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 13.0] [Reference Citation Analysis]
16 Qian H, Tao Y, Jiang L, Wang Y, Lan T, Wu M, Pang J, Appiah-Kubi K, Chen Y, Wu Y. PKG II effectively reversed EGF-induced protein expression alterations in human gastric cancer cell lines. Cell Biol Int 2018;42:435-42. [PMID: 29150923 DOI: 10.1002/cbin.10912] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
17 Sun DM, Tang BF, Li ZX, Guo HB, Cheng JL, Song PP, Zhao X. MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway. Sci Rep 2018;8:8007. [PMID: 29789623 DOI: 10.1038/s41598-018-26381-w] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
18 Sopha P, Phutubtim N, Chantrathonkul B, Ploypradith P, Ruchirawat S, Chittchang M. Roles of autophagy in relation to mitochondrial stress responses of HeLa cells to lamellarin cytotoxicity. Toxicology 2021;462:152963. [PMID: 34560126 DOI: 10.1016/j.tox.2021.152963] [Reference Citation Analysis]
19 Wei Z, Liu G, Jia R, Zhang W, Li L, Zhang Y, Wang Z, Bai X. Targeting secretory leukocyte protease inhibitor (SLPI) inhibits colorectal cancer cell growth, migration and invasion via downregulation of AKT. PeerJ 2020;8:e9400. [PMID: 32742768 DOI: 10.7717/peerj.9400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Shi J, Qu YP, Hou P. Pathogenetic mechanisms in gastric cancer. World J Gastroenterol 2014; 20(38): 13804-13819 [PMID: 25320518 DOI: 10.3748/wjg.v20.i38.13804] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 49] [Article Influence: 6.4] [Reference Citation Analysis]
21 Guo LY, Li YM, Qiao L, Liu T, Du YY, Zhang JQ, He WT, Zhao YX, He DQ. Notch2 regulates matrix metallopeptidase 9 via PI3K/AKT signaling in human gastric carcinoma cell MKN-45. World J Gastroenterol 2012; 18(48): 7262-7270 [PMID: 23326131 DOI: 10.3748/wjg.v18.i48.7262] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
22 Wei X, Shi J, Lin Q, Ma X, Pang Y, Mao H, Li R, Lu W, Wang Y, Liu P. Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K-AKT Pathway and Activating the AMPK-ROS Pathway. Front Oncol 2021;11:642229. [PMID: 33816292 DOI: 10.3389/fonc.2021.642229] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Fu Z, Zhen H, Zou F, Wang X, Chen Y, Liu L. Involvement of the Akt signaling pathway in ER-α36/GRP94-mediated signaling in gastric cancer. Oncol Lett. 2014;8:2077-2080. [PMID: 25295093 DOI: 10.3892/ol.2014.2514] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
24 Xia C, Zeng H, Zheng Y. Low‑intensity ultrasound enhances the antitumor effects of doxorubicin on hepatocellular carcinoma cells through the ROS‑miR‑21‑PTEN axis. Mol Med Rep 2020;21:989-98. [PMID: 32016465 DOI: 10.3892/mmr.2020.10936] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
25 Jiang BH, Liu LZ. Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment. Drug Resist Updat. 2008;11:63-76. [PMID: 18440854 DOI: 10.1016/j.drup.2008.03.001] [Cited by in Crossref: 153] [Cited by in F6Publishing: 158] [Article Influence: 10.9] [Reference Citation Analysis]
26 Li S, Zhu X, Liu B, Wang G, Ao P. Endogenous molecular network reveals two mechanisms of heterogeneity within gastric cancer. Oncotarget 2015;6:13607-27. [PMID: 25962957 DOI: 10.18632/oncotarget.3633] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
27 Han T, Wu N, Wang Y, Shen W, Zou J. miR‑16‑2‑3p inhibits cell proliferation and migration and induces apoptosis by targeting PDPK1 in maxillary primordium mesenchymal cells. Int J Mol Med 2019;43:1441-51. [PMID: 30664182 DOI: 10.3892/ijmm.2019.4070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Tomimaru Y, Eguchi H, Nagano H, Wada H, Tomokuni A, Kobayashi S, Marubashi S, Takeda Y, Tanemura M, Umeshita K. MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells. Br J Cancer. 2010;103:1617-1626. [PMID: 20978511 DOI: 10.1038/sj.bjc.6605958] [Cited by in Crossref: 134] [Cited by in F6Publishing: 125] [Article Influence: 11.2] [Reference Citation Analysis]
29 Sakamoto N, Oue N, Sentani K, Anami K, Uraoka N, Naito Y, Oo HZ, Hinoi T, Ohdan H, Yanagihara K. Liver-intestine cadherin induction by epidermal growth factor receptor is associated with intestinal differentiation of gastric cancer. Cancer Sci. 2012;103:1744-1750. [PMID: 22676223 DOI: 10.1111/j.1349-7006.2012.02353.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
30 Mannelli G, Gallo O. Cancer stem cells hypothesis and stem cells in head and neck cancers. Cancer Treat Rev 2012;38:515-39. [PMID: 22197808 DOI: 10.1016/j.ctrv.2011.11.007] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
31 Sun H, Zheng X, Wang Q, Yan J, Li D, Zhou Y, Lin Y, Zhang L, Wang X. Concurrent blockade of NF-κB and Akt pathways potentiates cisplatin’s antitumor activity in vivo. Anti-Cancer Drugs 2012;23:1039-46. [DOI: 10.1097/cad.0b013e32835679b8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
32 Fu XH, Chen ZT, Wang WH, Fan XJ, Huang Y, Wu XB, Huang JL, Wang JX, Lin HJ, Tan XL, Wang L, Wang JP. KRAS G12V Mutation is an Adverse Prognostic Factor of Chinese Gastric Cancer Patients. J Cancer. 2019;10:821-828. [PMID: 30854087 DOI: 10.7150/jca.27899] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
33 Liu X, Chu K. α-Actinin-4 promotes metastasis in gastric cancer. Lab Invest 2017;97:1084-94. [DOI: 10.1038/labinvest.2017.28] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
34 Hu Y, Ma Z, He Y, Liu W, Su Y, Tang Z. LncRNA-SNHG1 contributes to gastric cancer cell proliferation by regulating DNMT1. Biochem Biophys Res Commun. 2017;491:926-931. [PMID: 28754593 DOI: 10.1016/j.bbrc.2017.07.137] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 11.0] [Reference Citation Analysis]
35 Zheng HC. The molecular mechanisms of chemoresistance in cancers. Oncotarget 2017;8:59950-64. [PMID: 28938696 DOI: 10.18632/oncotarget.19048] [Cited by in Crossref: 236] [Cited by in F6Publishing: 241] [Article Influence: 47.2] [Reference Citation Analysis]
36 Matsuoka T, Yashiro M. The role of PI3K/Akt/mTOR signaling in gastric carcinoma. Cancers (Basel). 2014;6:1441-1463. [PMID: 25003395 DOI: 10.3390/cancers6031441] [Cited by in Crossref: 96] [Cited by in F6Publishing: 99] [Article Influence: 12.0] [Reference Citation Analysis]
37 Liu C, Wu H, Mao Y, Chen W, Chen S. Exosomal microRNAs in hepatocellular carcinoma. Cancer Cell Int 2021;21:254. [PMID: 33964930 DOI: 10.1186/s12935-021-01941-9] [Reference Citation Analysis]
38 Salem AF, Bonuccelli G, Bevilacqua G, Arafat H, Pestell RG, Sotgia F, Lisanti MP. Caveolin-1 promotes pancreatic cancer cell differentiation and restores membranous E-cadherin via suppression of the epithelial-mesenchymal transition. Cell Cycle 2011;10:3692-700. [PMID: 22041584 DOI: 10.4161/cc.10.21.17895] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
39 Jakobisiak M, Golab J. Statins can modulate effectiveness of antitumor therapeutic modalities. Med Res Rev. 2010;30:102-135. [PMID: 19526461 DOI: 10.1002/med.20162] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
40 Cinti C, Vindigni C, Zamparelli A, La Sala D, Epistolato MC, Marrelli D, Cevenini G, Tosi P. Activated Akt as an indicator of prognosis in gastric cancer. Virchows Arch. 2008;453:449-455. [PMID: 18841391 DOI: 10.1007/s00428-008-0676-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
41 Shi WJ, Gao JB. Molecular mechanisms of chemoresistance in gastric cancer. World J Gastrointest Oncol 2016; 8(9): 673-681 [PMID: 27672425 DOI: 10.4251/wjgo.v8.i9.673] [Cited by in CrossRef: 77] [Cited by in F6Publishing: 69] [Article Influence: 12.8] [Reference Citation Analysis]
42 Jou E, Rajdev L. Current and emerging therapies in unresectable and recurrent gastric cancer. World J Gastroenterol 2016; 22(20): 4812-4823 [PMID: 27239108 DOI: 10.3748/wjg.v22.i20.4812] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
43 Huang X, Li Z, Zhang Q, Wang W, Li B, Wang L, Xu Z, Zeng A, Zhang X, Zhang X, He Z, Li Q, Sun G, Wang S, Li Q, Wang L, Zhang L, Xu H, Xu Z. Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression. Mol Cancer. 2019;18:71. [PMID: 30927924 DOI: 10.1186/s12943-019-0969-3] [Cited by in Crossref: 130] [Cited by in F6Publishing: 150] [Article Influence: 43.3] [Reference Citation Analysis]
44 Ng CF, Ng PK, Lui VW, Li J, Chan JY, Fung KP, Ng YK, Lai PB, Tsui SK. FHL2 exhibits anti-proliferative and anti-apoptotic activities in liver cancer cells. Cancer Lett 2011;304:97-106. [PMID: 21377781 DOI: 10.1016/j.canlet.2011.02.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
45 Lai CK, Lu YL, Hsieh JT, Tsai SC, Feng CL, Tsai YS, Tsai PC, Su HL, Lin YH, Lai CH. Development of chitosan/heparin nanoparticle-encapsulated cytolethal distending toxin for gastric cancer therapy. Nanomedicine (Lond) 2014;9:803-17. [PMID: 24024568 DOI: 10.2217/nnm.13.54] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
46 Lazăr DC, Tăban S, Cornianu M, Faur A, Goldiş A. New advances in targeted gastric cancer treatment. World J Gastroenterol 2016; 22(30): 6776-6799 [PMID: 27570417 DOI: 10.3748/wjg.v22.i30.6776] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 47] [Article Influence: 8.0] [Reference Citation Analysis]
47 Ruan T, Liu W, Tao K, Wu C. A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer. Onco Targets Ther 2020;13:1797-807. [PMID: 32184615 DOI: 10.2147/OTT.S239336] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
48 Salm F, Dimitrova V, von Bueren AO, Ćwiek P, Rehrauer H, Djonov V, Anderle P, Arcaro A. The Phosphoinositide 3-Kinase p110α Isoform Regulates Leukemia Inhibitory Factor Receptor Expression via c-Myc and miR-125b to Promote Cell Proliferation in Medulloblastoma. PLoS One 2015;10:e0123958. [PMID: 25915540 DOI: 10.1371/journal.pone.0123958] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
49 Yang Q, Shao Y, Shi J, Qu Y, Wu K, Dang S, Shi B, Hou P. Concomitant PIK3CA amplification and RASSF1A or PAX6 hypermethylation predict worse survival in gastric cancer. Clin Biochem. 2014;47:111-116. [PMID: 24505629 DOI: 10.1016/j.clinbiochem.2013.10.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
50 Fattahi S, Amjadi-Moheb F, Tabaripour R, Ashrafi GH, Akhavan-Niaki H. PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond. Life Sci 2020;262:118513. [PMID: 33011222 DOI: 10.1016/j.lfs.2020.118513] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
51 Zhang D, Fan D. New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives. Future Oncol. 2010;6:527-537. [PMID: 20373867 DOI: 10.2217/fon.10.21] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 6.0] [Reference Citation Analysis]
52 Price ZK, Lokman NA, Ricciardelli C. Differing Roles of Hyaluronan Molecular Weight on Cancer Cell Behavior and Chemotherapy Resistance. Cancers (Basel) 2018;10:E482. [PMID: 30513961 DOI: 10.3390/cancers10120482] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
53 Lei YP, Chen HX, Zhou XD. MiR-126 regulates the expression of vascular endothelial growth factor A and its downstream target proteins Akt, mTOR and Erk1/2 in gastric cancer cells. Shijie Huaren Xiaohua Zazhi 2013; 21(36): 4116-4120 [DOI: 10.11569/wcjd.v21.i36.4116] [Reference Citation Analysis]
54 Hirsch E, Ciraolo E, Ghigo A, Costa C. Taming the PI3K team to hold inflammation and cancer at bay. Pharmacol Ther. 2008;118:192-205. [PMID: 18420279 DOI: 10.1016/j.pharmthera.2008.02.004] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 3.7] [Reference Citation Analysis]
55 Al-Bahlani S, Burney IA, Al-Dhahli B, Al-Kharusi S, Al-Kharousi F, Al-Kalbani A, Ahmed I. Boswellic acid sensitizes gastric cancer cells to Cisplatin-induced apoptosis via p53-mediated pathway. BMC Pharmacol Toxicol 2020;21:64. [PMID: 32867831 DOI: 10.1186/s40360-020-00442-1] [Reference Citation Analysis]
56 Huang L, Ma J, Sun Y, Lv Y, Lin W, Liu M, Tu C, Zhou P, Gu W, Su S, Zhang G. Altered splenic miRNA expression profile in H1N1 swine influenza. Arch Virol 2015;160:979-85. [DOI: 10.1007/s00705-015-2351-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
57 Pastwa E, Somiari RI, Malinowski M, Somiari SB, Winters TA. In vitro non-homologous DNA end joining assays--the 20th anniversary. Int J Biochem Cell Biol 2009;41:1254-60. [PMID: 19110069 DOI: 10.1016/j.biocel.2008.11.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
58 Caster JM, Sethi M, Kowalczyk S, Wang E, Tian X, Nabeel Hyder S, Wagner KT, Zhang YA, Kapadia C, Man Au K, Wang AZ. Nanoparticle delivery of chemosensitizers improve chemotherapy efficacy without incurring additional toxicity. Nanoscale 2015;7:2805-11. [PMID: 25584654 DOI: 10.1039/c4nr07102f] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
59 Verma HK, Falco G, Bhaskar LVKS. Molecular Signaling Pathways Involved in Gastric Cancer Chemoresistance. In: Raju GSR, Bhaskar L, editors. Theranostics Approaches to Gastric and Colon Cancer. Singapore: Springer; 2020. pp. 117-34. [DOI: 10.1007/978-981-15-2017-4_8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
60 Huang WS, Wang TB, He Y, Chen YJ, Zhong SL, Tan M. Phosphoinositide-3-kinase, catalytic, alpha polypeptide RNA interference inhibits growth of colon cancer cell SW948. World J Gastroenterol 2012; 18(26): 3458-3464 [PMID: 22807617 DOI: 10.3748/wjg.v18.i26.3458] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
61 Harbison RA, Kubik M, Konnick EQ, Zhang Q, Lee SG, Park H, Zhang J, Carlson CS, Chen C, Schwartz SM, Rodriguez CP, Duvvuri U, Méndez E. The mutational landscape of recurrent versus nonrecurrent human papillomavirus-related oropharyngeal cancer. JCI Insight 2018;3:99327. [PMID: 30046007 DOI: 10.1172/jci.insight.99327] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
62 Baghery Saghchy Khorasani A, Pourbagheri-Sigaroodi A, Pirsalehi A, Safaroghli-Azar A, Zali MR, Bashash D. The PI3K/Akt/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for pharmacologic interventions. Eur J Pharmacol 2021;898:173983. [PMID: 33647255 DOI: 10.1016/j.ejphar.2021.173983] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
63 Qiao L, Wong BC. Targeting apoptosis as an approach for gastrointestinal cancer therapy. Drug Resist Updat. 2009;12:55-64. [PMID: 19278896 DOI: 10.1016/j.drup.2009.02.002] [Cited by in Crossref: 89] [Cited by in F6Publishing: 81] [Article Influence: 6.8] [Reference Citation Analysis]
64 Moon JY, Manh Hung LV, Unno T, Cho SK. Nobiletin Enhances Chemosensitivity to Adriamycin through Modulation of the Akt/GSK3β/β⁻Catenin/MYCN/MRP1 Signaling Pathway in A549 Human Non-Small-Cell Lung Cancer Cells. Nutrients 2018;10:E1829. [PMID: 30486290 DOI: 10.3390/nu10121829] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
65 Shi J, Yao D, Liu W, Wang N, Lv H, Zhang G, Ji M, Xu L, He N, Shi B. Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer. BMC Cancer. 2012;12:50. [PMID: 22292935 DOI: 10.1186/1471-2407-12-50] [Cited by in Crossref: 82] [Cited by in F6Publishing: 85] [Article Influence: 8.2] [Reference Citation Analysis]
66 Kim S, Barzi A, Rajdev L. Biomarker-driven targeted therapies for gastric/gastro-esophageal junction malignancies. Semin Oncol. 2018;45:133-150. [PMID: 30262395 DOI: 10.1053/j.seminoncol.2018.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
67 Zhou W, Tan W, Huang X, Yu HG. Doxorubicin combined with Notch1-targeting siRNA for the treatment of gastric cancer. Oncol Lett 2018;16:2805-12. [PMID: 30127866 DOI: 10.3892/ol.2018.9039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
68 Zhou Y, Sha Z, Yang Y, Wu S, Chen H. lncRNA NEAT1 regulates gastric carcinoma cell proliferation, invasion and apoptosis via the miR‑500a‑3p/XBP‑1 axis. Mol Med Rep 2021;24:503. [PMID: 33982777 DOI: 10.3892/mmr.2021.12142] [Reference Citation Analysis]
69 Zhang Y, Chen L, Cao Y, Chen S, Xu C, Xing J, Zhang K. LETM1 Promotes Gastric Cancer Cell Proliferation, Migration, and Invasion via the PI3K/Akt Signaling Pathway. J Gastric Cancer 2020;20:139-51. [PMID: 32595998 DOI: 10.5230/jgc.2020.20.e12] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
70 Oh TI, Lee JH, Kim S, Nam TJ, Kim YS, Kim BM, Yim WJ, Lim JH. Fascaplysin Sensitizes Anti-Cancer Effects of Drugs Targeting AKT and AMPK. Molecules 2017;23:E42. [PMID: 29295560 DOI: 10.3390/molecules23010042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
71 Singh S, Ramamoorthy M, Vaughan C, Yeudall WA, Deb S, Palit Deb S. Human oncoprotein MDM2 activates the Akt signaling pathway through an interaction with the repressor element-1 silencing transcription factor conferring a survival advantage to cancer cells. Cell Death Differ 2013;20:558-66. [PMID: 23238568 DOI: 10.1038/cdd.2012.153] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
72 Wang Y, Xu S, Xiong W, Pei Y, Li B, Chen Y. Nanogels fabricated from bovine serum albumin and chitosan via self-assembly for delivery of anticancer drug. Colloids Surf B Biointerfaces 2016;146:107-13. [PMID: 27262260 DOI: 10.1016/j.colsurfb.2016.05.043] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
73 Zhou L, Li X, Zhou F, Jin Z, Chen D, Wang P, Zhang S, Zhuge Y, Shang Y, Zou X. Downregulation of leucine-rich repeats and immunoglobulin-like domains 1 by microRNA-20a modulates gastric cancer multidrug resistance. Cancer Sci. 2018;109:1044-1054. [PMID: 29450946 DOI: 10.1111/cas.13538] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
74 Khattak MA, Martin HL, Karapetis CS. Targeted therapy for esophagogastric cancers: a review. Onco Targets Ther 2012;5:91-102. [PMID: 22719211 DOI: 10.2147/OTT.S25117] [Reference Citation Analysis]
75 Zeng S, Tao Y, Huang J, Zhang S, Shen L, Yang H, Pei H, Zhong M, Zhang G, Liu T, Zhou M, Shen H. WD40 repeat-containing 62 overexpression as a novel indicator of poor prognosis for human gastric cancer. Eur J Cancer 2013;49:3752-62. [PMID: 23920402 DOI: 10.1016/j.ejca.2013.07.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
76 Dehghanzadeh R, Jadidi-Niaragh F, Gharibi T, Yousefi M. MicroRNA-induced drug resistance in gastric cancer. Biomed Pharmacother. 2015;74:191-199. [PMID: 26349984 DOI: 10.1016/j.biopha.2015.08.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
77 Fu YC, Zhang QY. Advances in gastroma angiogenesis and antiangiogenesis treatment for gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2008; 16(18): 2012-2018 [DOI: 10.11569/wcjd.v16.i18.2012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
78 Gallotta D, Nigro P, Cotugno R, Gazzerro P, Bifulco M, Belisario MA. Rimonabant-induced apoptosis in leukemia cell lines: activation of caspase-dependent and -independent pathways. Biochem Pharmacol 2010;80:370-80. [PMID: 20417624 DOI: 10.1016/j.bcp.2010.04.023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
79 Loh AH, Brennan RC, Lang WH, Hickey RJ, Malkas LH, Sandoval JA. Dissecting the PI3K Signaling Axis in Pediatric Solid Tumors: Novel Targets for Clinical Integration. Front Oncol 2013;3:93. [PMID: 23638435 DOI: 10.3389/fonc.2013.00093] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
80 Plati J, Bucur O, Khosravi-Far R. Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities. J Cell Biochem 2008;104:1124-49. [PMID: 18459149 DOI: 10.1002/jcb.21707] [Cited by in Crossref: 103] [Cited by in F6Publishing: 103] [Article Influence: 7.4] [Reference Citation Analysis]
81 Ying L, Zu-an Z, Qing-hua L, Qing-yan K, Lei L, Tao C, Yong-ping W. RAD001 can reverse drug resistance of SGC7901/DDP cells. Tumor Biol 2014;35:9171-7. [DOI: 10.1007/s13277-014-1719-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
82 Zhou XD, Chen HX, Guan RN, Lei YP, Shu X, Zhu Y, Lv NH. Protein kinase B phosphorylation correlates with vascular endothelial growth factor A and microvessel density in gastric adenocarcinoma. J Int Med Res 2012;40:2124-34. [PMID: 23321169 DOI: 10.1177/030006051204000610] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
83 Ma Z, Yang J, Yang Y, Wang X, Chen G, Shi A, Lu Y, Jia S, Kang X, Lu L. Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway. Phytomedicine 2020;68:153186. [PMID: 32088353 DOI: 10.1016/j.phymed.2020.153186] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
84 Huang WC, Hung MC. Induction of Akt activity by chemotherapy confers acquired resistance. J Formos Med Assoc. 2009;108:180-194. [PMID: 19293033 DOI: 10.1016/S0929-6646(09)60051-6] [Cited by in Crossref: 79] [Cited by in F6Publishing: 49] [Article Influence: 6.1] [Reference Citation Analysis]
85 Ku GY, Ilson DH. Emerging tyrosine kinase inhibitors for esophageal cancer. Expert Opin Emerg Drugs. 2013;18:219-230. [PMID: 23725567 DOI: 10.1517/14728214.2013.805203] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
86 Oshima T, Masuda M. Molecular targeted agents for gastric and gastroesophageal junction cancer. Surg Today 2012;42:313-27. [PMID: 22127535 DOI: 10.1007/s00595-011-0065-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
87 Wu KN, Zhao YM, He Y, Wang BS, Du KL, Fu S, Hu KM, Zhang LF, Liu LZ, Hu YX, Wang YJ, Huang H. Rapamycin interacts synergistically with idarubicin to induce T-leukemia cell apoptosis in vitro and in a mesenchymal stem cell simulated drug-resistant microenvironment via Akt/mammalian target of rapamycin and extracellular signal-related kinase signaling pathways. Leuk Lymphoma 2014;55:668-76. [PMID: 23741975 DOI: 10.3109/10428194.2013.811579] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
88 Riganti C, Doublier S, Costamagna C, Aldieri E, Pescarmona G, Ghigo D, Bosia A. Activation of Nuclear Factor-κB Pathway by Simvastatin and RhoA Silencing Increases Doxorubicin Cytotoxicity in Human Colon Cancer HT29 Cells. Mol Pharmacol 2008;74:476-84. [DOI: 10.1124/mol.108.045286] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
89 Yang S, Huang C, Li X, Yu M, He Y, Li J. miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN. Toxicology 2013;306:162-8. [DOI: 10.1016/j.tox.2013.02.014] [Cited by in Crossref: 129] [Cited by in F6Publishing: 133] [Article Influence: 14.3] [Reference Citation Analysis]
90 Khalafi S, Zhu S, Khurana R, Lohse I, Giordano S, Corso S, Al-Ali H, Brothers SP, Wahlestedt C, Schürer S, El-Rifai W. A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer. Transl Oncol 2021;15:101260. [PMID: 34735897 DOI: 10.1016/j.tranon.2021.101260] [Reference Citation Analysis]
91 Bashash D, Delshad M, Riyahi N, Safaroghli-azar A, Pourbagheri-sigaroodi A, Momeny M. Inhibition of PI3K signaling pathway enhances the chemosensitivity of APL cells to ATO: Proposing novel therapeutic potential for BKM120. European Journal of Pharmacology 2018;841:10-8. [DOI: 10.1016/j.ejphar.2018.10.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
92 Zangouei AS, Moghbeli M. MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells. Genes Environ 2021;43:21. [PMID: 34099061 DOI: 10.1186/s41021-021-00192-4] [Reference Citation Analysis]
93 Isakoff SJ, Tabernero J, Molife LR, Soria JC, Cervantes A, Vogelzang NJ, Patel MR, Hussain M, Baron A, Argilés G, Conkling PR, Sampath D, Maslyar D, Patel P, Chan W, Gendreau S, Musib L, Xu N, Ma H, Lin K, Bendell J. Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors. Ann Oncol 2020;31:626-33. [PMID: 32205017 DOI: 10.1016/j.annonc.2020.02.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
94 Zhao Y, Yang X. The Hippo pathway in chemotherapeutic drug resistance: Hippo pathway and drug resistance. Int J Cancer 2015;137:2767-73. [DOI: 10.1002/ijc.29293] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 6.5] [Reference Citation Analysis]
95 Bezler M, Hengstler JG, Ullrich A. Inhibition of doxorubicin-induced HER3-PI3K-AKT signalling enhances apoptosis of ovarian cancer cells. Mol Oncol 2012;6:516-29. [PMID: 22841590 DOI: 10.1016/j.molonc.2012.07.001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 4.9] [Reference Citation Analysis]
96 Zhang J, Zhang LL, Shen L, Xu XM, Yu HG. Regulation of AKT gene expression by cisplatin. Oncol Lett 2013;5:756-60. [PMID: 23426872 DOI: 10.3892/ol.2013.1132] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
97 Li C, Zhao J, Sun W. microRNA-222-Mediated VHL Downregulation Facilitates Retinoblastoma Chemoresistance by Increasing HIF1α Expression. Invest Ophthalmol Vis Sci 2020;61:9. [PMID: 32756923 DOI: 10.1167/iovs.61.10.9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
98 Bian C, Liu Z, Li D, Zhen L. PI3K/AKT inhibition induces compensatory activation of the MET/STAT3 pathway in non-small cell lung cancer. Oncol Lett 2018;15:9655-62. [PMID: 29928341 DOI: 10.3892/ol.2018.8587] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
99 Ding K, Wu Z, Wang N, Wang X, Wang Y, Qian P, Meng G, Tan S. MiR-26a performs converse roles in proliferation and metastasis of different gastric cancer cells via regulating of PTEN expression. Pathol Res Pract 2017;213:467-75. [PMID: 28242043 DOI: 10.1016/j.prp.2017.01.026] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
100 Wallin JJ, Guan J, Prior WW, Edgar KA, Kassees R, Sampath D, Belvin M, Friedman LS. Nuclear phospho-Akt increase predicts synergy of PI3K inhibition and doxorubicin in breast and ovarian cancer. Sci Transl Med 2010;2:48ra66. [PMID: 20826841 DOI: 10.1126/scitranslmed.3000630] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
101 Akagi H, Higuchi H, Sumimoto H, Igarashi T, Kabashima A, Mizuguchi H, Izumiya M, Sakai G, Adachi M, Funakoshi S. Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells. Gastric Cancer. 2013;16:100-110. [PMID: 22527182 DOI: 10.1007/s10120-012-0153-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
102 Mukherjee A, Samanta S, Karmakar P. Inactivation of PTEN is responsible for the survival of Hep G2 cells in response to etoposide-induced damage. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2011;715:42-51. [DOI: 10.1016/j.mrfmmm.2011.07.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
103 Ding H, Sun J, Li R, Wang G. Retracted Article: Long non-coding RNA GACAT1 alleviates doxorubicin and vincristine resistance through a PTEN/AKT/mTOR/S6K1 regulatory pathway in gastric cancer. RSC Adv 2019;9:8048-55. [DOI: 10.1039/c8ra10030f] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
104 Almhanna K. Targeted Therapy for Gastric Adenocarcinoma. Current Challenges in Personalized Cancer Medicine. Elsevier; 2012. pp. 437-70. [DOI: 10.1016/b978-0-12-397927-8.00014-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
105 Michaelis M, Hinsch N, Michaelis UR, Rothweiler F, Simon T, ilhelm Doerr HW, Cinatl J, Cinatl J Jr. Chemotherapy-associated angiogenesis in neuroblastoma tumors. Am J Pathol 2012;180:1370-7. [PMID: 22285670 DOI: 10.1016/j.ajpath.2011.12.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
106 Ai Y, Zhou Q, Li L, Pan Z, Guo M, Han J. Interference of P-REX2a may inhibit proliferation and reverse the resistance of SGC7901 cells to doxorubicin. Oncol Lett 2018;15:3185-91. [PMID: 29435055 DOI: 10.3892/ol.2017.7693] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
107 Zhang J, Zhang QY. Application of PI3K/Akt and COX-2 signal pathway blockage in treatment of gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2009; 17(6): 584-588 [DOI: 10.11569/wcjd.v17.i6.584] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
108 Alessandrini L, Manchi M, De Re V, Dolcetti R, Canzonieri V. Proposed Molecular and miRNA Classification of Gastric Cancer. Int J Mol Sci 2018;19:E1683. [PMID: 29882766 DOI: 10.3390/ijms19061683] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
109 Wang F, Li T, Zhang B, Li H, Wu Q, Yang L, Nie Y, Wu K, Shi Y, Fan D. MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN. Biochem Biophys Res Commun. 2013;434:688-694. [PMID: 23603256 DOI: 10.1016/j.bbrc.2013.04.010] [Cited by in Crossref: 109] [Cited by in F6Publishing: 102] [Article Influence: 12.1] [Reference Citation Analysis]
110 Li Y, Qu X, Qu J, Zhang Y, Liu J, Teng Y, Hu X, Hou K, Liu Y. Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation. Cancer Lett. 2009;284:208-215. [PMID: 19457607 DOI: 10.1016/j.canlet.2009.04.035] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 4.6] [Reference Citation Analysis]
111 McDonald GT, Sullivan R, Paré GC, Graham CH. Inhibition of phosphatidylinositol 3-kinase promotes tumor cell resistance to chemotherapeutic agents via a mechanism involving delay in cell cycle progression. Exp Cell Res 2010;316:3197-206. [PMID: 20736003 DOI: 10.1016/j.yexcr.2010.08.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
112 Zhao L, Pan Y, Gang Y, Wang H, Jin H, Tie J, Xia L, Zhang Y, He L, Yao L, Qiao T, Li T, Liu Z, Fan D. Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA library. J Biol Chem 2009;284:26273-85. [PMID: 19638344 DOI: 10.1074/jbc.M109.028068] [Cited by in Crossref: 35] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
113 Liu J, Fu XQ, Zhou W, Yu HG, Yu JP, Luo HS. LY294002 potentiates the anti-cancer effect of oxaliplatin for gastric cancer via death receptor pathway. World J Gastroenterol 2011; 17(2): 181-190 [PMID: 21245990 DOI: 10.3748/wjg.v17.i2.181] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
114 Yu J, Gao J, Lu Z, Gong J, Li Y, Dong B, Li Z, Zhang X, Shen L. Combination of microtubule associated protein-tau and β-tubulin III predicts chemosensitivity of paclitaxel in patients with advanced gastric cancer. Eur J Cancer 2014;50:2328-35. [PMID: 25016949 DOI: 10.1016/j.ejca.2014.06.017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
115 Zhu J, Sun Y, Lu Y, Jiang X, Ma B, Yu L, Zhang J, Dong X, Zhang Q. Glaucocalyxin A exerts anticancer effect on osteosarcoma by inhibiting GLI1 nuclear translocation via regulating PI3K/Akt pathway. Cell Death Dis 2018;9:708. [PMID: 29899333 DOI: 10.1038/s41419-018-0684-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
116 Hill R, Li Y, Tran LM, Dry S, Calvopina JH, Garcia A, Kim C, Wang Y, Donahue TR, Herschman HR. Cell intrinsic role of COX-2 in pancreatic cancer development. Mol Cancer Ther. 2012;11:2127-2137. [PMID: 22784710 DOI: 10.1158/1535-7163.mct-12-0342] [Cited by in Crossref: 48] [Cited by in F6Publishing: 33] [Article Influence: 4.8] [Reference Citation Analysis]
117 Yu B, Xie J. Identifying therapeutic targets in gastric cancer: the current status and future direction. Acta Biochim Biophys Sin (Shanghai) 2016;48:90-6. [PMID: 26373844 DOI: 10.1093/abbs/gmv084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 0.1] [Reference Citation Analysis]
118 Kartal-yandim M, Adan-gokbulut A, Baran Y. Molecular mechanisms of drug resistance and its reversal in cancer. Critical Reviews in Biotechnology 2016;36:716-26. [DOI: 10.3109/07388551.2015.1015957] [Cited by in Crossref: 145] [Cited by in F6Publishing: 141] [Article Influence: 20.7] [Reference Citation Analysis]
119 Fattahi S, Kosari-Monfared M, Golpour M, Emami Z, Ghasemiyan M, Nouri M, Akhavan-Niaki H. LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine. J Cell Physiol. 2020;235:3189-3206. [PMID: 31595495 DOI: 10.1002/jcp.29260] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
120 Fu X, Liu M, Qu S, Ma J, Zhang Y, Shi T, Wen H, Yang Y, Wang S, Wang J, Nan K, Yao Y, Tian T. Exosomal miR-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway. J Exp Clin Cancer Res. 2018;37:52. [PMID: 29530052 DOI: 10.1186/s13046-018-0677-7] [Cited by in Crossref: 79] [Cited by in F6Publishing: 87] [Article Influence: 19.8] [Reference Citation Analysis]
121 Yang Z, Lv NH. Role of PTEN in gastric carcinogenesis. Shijie Huaren Xiaohua Zazhi 2011; 19(6): 608-613 [DOI: 10.11569/wcjd.v19.i6.608] [Reference Citation Analysis]
122 Zhou W, Fu XQ, Liu J, Yu HG. RNAi knockdown of the Akt1 gene increases the chemosensitivity of gastric cancer cells to cisplatin both in vitro and in vivo. Regul Pept. 2012;176:13-21. [PMID: 22387880 DOI: 10.1016/j.regpep.2012.02.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
123 Garofalo M, Quintavalle C, Zanca C, De Rienzo A, Romano G, Acunzo M, Puca L, Incoronato M, Croce CM, Condorelli G. Akt regulates drug-induced cell death through Bcl-w downregulation. PLoS One 2008;3:e4070. [PMID: 19114998 DOI: 10.1371/journal.pone.0004070] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
124 Kothari N, Almhanna K. Current status of novel agents in advanced gastroesophageal adenocarcinoma. J Gastrointest Oncol. 2015;6:60-74. [PMID: 25642339 DOI: 10.3978/j.issn.2078-6891.2014.098] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
125 He HN, Wang X, Zheng XL, Sun H, Shi XW, Zhong YJ, Huang B, Yang L, Li JK, Liao LC, Zhang L, Hu LN, Lin Y. Concurrent blockade of the NF-kappaB and Akt pathways potently sensitizes cancer cells to chemotherapeutic-induced cytotoxicity. Cancer Lett 2010;295:38-43. [PMID: 20207071 DOI: 10.1016/j.canlet.2010.02.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
126 Rohr UD, Gocan AG, Bachg D, Schindler AE. Cancer protection of soy resembles cancer protection during pregnancy. Hormone Molecular Biology and Clinical Investigation 2010;3. [DOI: 10.1515/hmbci.2010.063] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
127 Xia LJ, Wu YL, Zhang FC. Combination of cecropinXJ and LY294002 induces synergistic cytotoxicity, and apoptosis in human gastric cancer cells via inhibition of the PI3K/Akt signaling pathway. Oncol Lett 2017;14:7522-8. [PMID: 29344198 DOI: 10.3892/ol.2017.7112] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
128 Zhou W, Fu XQ, Zhang LL, Zhang J, Huang X, Lu XH, Shen L, Liu BN, Liu J, Luo HS, Yu JP, Yu HG. The AKT1/NF-kappaB/Notch1/PTEN axis has an important role in chemoresistance of gastric cancer cells. Cell Death Dis 2013;4:e847. [PMID: 24113181 DOI: 10.1038/cddis.2013.375] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
129 Ku GY, Ilson DH. Esophagogastric cancer: targeted agents. Cancer Treat Rev. 2010;36:235-248. [PMID: 20122806 DOI: 10.1016/j.ctrv.2009.12.009] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
130 Wu X, Zhang Y, Guo J, Yan X, Shen L, Zhou J, Zhao J, Zhuang M, Cao Z. MAC30 Knockdown Inhibits Proliferation and Enhance Apoptosis of Gastric Cancer by Suppressing Wnt/β-Cateninsignaling Pathway. Gastroenterol Res Pract 2020;2020:6358685. [PMID: 32904598 DOI: 10.1155/2020/6358685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
131 Son ES, Kim SH, Kim YO, Lee YE, Kyung SY, Jeong SH, Kim YJ, Park JW. Coix lacryma-jobi var. ma-yuen Stapf sprout extract induces cell cycle arrest and apoptosis in human cervical carcinoma cells. BMC Complement Altern Med 2019;19:312. [PMID: 31729992 DOI: 10.1186/s12906-019-2725-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
132 Tesei A, Leonetti C, Zupi G, Scarsella M, Brigliadori G, Ulivi P, Fabbri F, Arienti C, Amadori D, Passardi A, Silvestrini R, Zoli W. Low-dose taxotere enhances the ability of sorafenib to induce apoptosis in gastric cancer models. J Cell Mol Med 2011;15:316-26. [PMID: 20015197 DOI: 10.1111/j.1582-4934.2009.00993.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
133 Cai Z, Ke J, He X, Yuan R, Chen Y, Wu X, Wang L, Wang J, Lan P, Wu X. Significance of mTOR signaling and its inhibitor against cancer stem-like cells in colorectal cancer. Ann Surg Oncol. 2014;21:179-188. [PMID: 23907312 DOI: 10.1245/s10434-013-3146-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
134 Wang R, Zheng X, Zhang L, Zhou B, Hu H, Li Z, Zhang L, Lin Y, Wang X. Histone H4 expression is cooperatively maintained by IKKβ and Akt1 which attenuates cisplatin-induced apoptosis through the DNA-PK/RIP1/IAPs signaling cascade. Sci Rep 2017;7:41715. [PMID: 28139737 DOI: 10.1038/srep41715] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
135 Surucu B, Bozulic L, Hynx D, Parcellier A, Hemmings BA. In vivo analysis of protein kinase B (PKB)/Akt regulation in DNA-PKcs-null mice reveals a role for PKB/Akt in DNA damage response and tumorigenesis. J Biol Chem 2008;283:30025-33. [PMID: 18757368 DOI: 10.1074/jbc.M803053200] [Cited by in Crossref: 56] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]